Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models

被引:36
作者
Fronton, Ludivine [1 ,2 ,3 ]
Pilari, Sabine [2 ,3 ,4 ]
Huisinga, Wilhelm [5 ]
机构
[1] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany
[2] Free Univ Berlin, Grad Res Training Program PharMetrX Pharmacometr, Berlin, Germany
[3] Univ Potsdam, Berlin, Germany
[4] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany
[5] Univ Potsdam, Inst Math, Potsdam, Germany
关键词
mAb disposition; PBPK; Extravasation rate-limited tissue model; Classical compartment model; MEDIATED DRUG DISPOSITION; PHARMACOKINETIC MODEL; CLINICAL PHARMACOKINETICS; MICE; IGG; IMMUNOGLOBULIN; CATABOLISM; FCRN; CHARACTERIZE; PARAMETERS;
D O I
10.1007/s10928-014-9349-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The structure, interpretation and parameterization of classical compartment models as well as physiologically-based pharmacokinetic (PBPK) models for monoclonal antibody (mAb) disposition are very diverse, with no apparent consensus. In addition, there is a remarkable discrepancy between the simplicity of experimental plasma and tissue profiles and the complexity of published PBPK models. We present a simplified PBPK model based on an extravasation rate-limited tissue model with elimination potentially occurring from various tissues and plasma. Based on model reduction (lumping), we derive several classical compartment model structures that are consistent with the simplified PBPK model and experimental data. We show that a common interpretation of classical two-compartment models for mAb disposition-identifying the central compartment with the total plasma volume and the peripheral compartment with the interstitial space (or part of it)-is not consistent with current knowledge. Results are illustrated for the monoclonal antibodies 7E3 and T84.66 in mice.
引用
收藏
页码:87 / 107
页数:21
相关论文
共 49 条
[1]   Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism [J].
Akilesh, Shreeram ;
Christianson, Gregory J. ;
Roopenian, Derry C. ;
Shaw, Andrey S. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (07) :4580-4588
[2]  
Azzopardi N, 2010, POP APPR GROUP M
[3]  
BAXTER LT, 1994, CANCER RES, V54, P1517
[4]   Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice [J].
Borvak, J ;
Richardson, J ;
Medesan, C ;
Antohe, F ;
Radu, C ;
Simionescu, M ;
Ghetie, V ;
Ward, ES .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (09) :1289-1298
[5]   THEORETICAL MODEL OF GAMMA-GLOBULIN CATABOLISM [J].
BRAMBELL, FW ;
HEMMINGS, WA ;
MORRIS, IG .
NATURE, 1964, 203 (495) :1352-&
[6]   Physiological parameter values for physiologically based pharmacokinetic models [J].
Brown, RP ;
Delp, MD ;
Lindstedt, SL ;
Rhomberg, LR ;
Beliles, RP .
TOXICOLOGY AND INDUSTRIAL HEALTH, 1997, 13 (04) :407-484
[7]   Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies [J].
Cao, Yanguang ;
Balthasar, Joseph P. ;
Jusko, William J. .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 (05) :597-607
[8]   Evaluation of a Catenary PBPK Model for Predicting the In Vivo Disposition of mAbs Engineered for High-Affinity Binding to FcRn [J].
Chen, Yang ;
Balthasar, Joseph P. .
AAPS JOURNAL, 2012, 14 (04) :850-859
[9]  
COVELL DG, 1986, CANCER RES, V46, P3969
[10]   A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs [J].
Davda, Jasmine P. ;
Jain, Maneesh ;
Batra, Surinder K. ;
Gwilt, Peter R. ;
Robinson, Dennis H. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (03) :401-413